152 related articles for article (PubMed ID: 9081685)
1. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins.
Hurt-Camejo E; Andersen S; Standal R; Rosengren B; Sartipy P; Stadberg E; Johansen B
Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):300-9. PubMed ID: 9081685
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries.
Romano M; Romano E; Björkerud S; Hurt-Camejo E
Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):519-25. PubMed ID: 9555856
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixes.
Sartipy P; Bondjers G; Hurt-Camejo E
Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1934-41. PubMed ID: 9848887
[TBL] [Abstract][Full Text] [Related]
4. Mildly oxidized LDL induces expression of group IIa secretory phospholipase A(2) in human monocyte-derived macrophages.
Anthonsen MW; Stengel D; Hourton D; Ninio E; Johansen B
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1276-82. PubMed ID: 10807743
[TBL] [Abstract][Full Text] [Related]
5. Expression of phospholipase A2 isoforms in human normal and atherosclerotic arterial wall.
Elinder LS; Dumitrescu A; Larsson P; Hedin U; Frostegård J; Claesson HE
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2257-63. PubMed ID: 9351398
[TBL] [Abstract][Full Text] [Related]
6. Secretory group II phospholipase A2 in human atherosclerotic plaques.
Menschikowski M; Kasper M; Lattke P; Schiering A; Schiefer S; Stockinger H; Jaross W
Atherosclerosis; 1995 Dec; 118(2):173-81. PubMed ID: 8770312
[TBL] [Abstract][Full Text] [Related]
7. New phospholipase A(2) isozymes with a potential role in atherosclerosis.
Murakami M; Kudo I
Curr Opin Lipidol; 2003 Oct; 14(5):431-6. PubMed ID: 14501581
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.
Häkkinen T; Luoma JS; Hiltunen MO; Macphee CH; Milliner KJ; Patel L; Rice SQ; Tew DG; Karkola K; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2909-17. PubMed ID: 10591668
[TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 in juvenile rheumatoid arthritis: correlation to disease type and activity.
Pruzanski W; Albin-Cook K; Laxer RM; MacMillan J; Stefanski E; Vadas P; Silverman ED
J Rheumatol; 1994 Oct; 21(10):1951-4. PubMed ID: 7837165
[TBL] [Abstract][Full Text] [Related]
10. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
Hanasaki K; Yamada K; Yamamoto S; Ishimoto Y; Saiga A; Ono T; Ikeda M; Notoya M; Kamitani S; Arita H
J Biol Chem; 2002 Aug; 277(32):29116-24. PubMed ID: 12021277
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines.
Uzui H; Harpf A; Liu M; Doherty TM; Shukla A; Chai NN; Tripathi PV; Jovinge S; Wilkin DJ; Asotra K; Shah PK; Rajavashisth TB
Circulation; 2002 Dec; 106(24):3024-30. PubMed ID: 12473546
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for the association of group IIA phospholipase A(2) and decorin in human atherosclerotic lesions.
Sartipy P; Johansen B; Gâsvik K; Hurt-Camejo E
Circ Res; 2000 Mar; 86(6):707-14. PubMed ID: 10747008
[TBL] [Abstract][Full Text] [Related]
13. Binding of human phospholipase A2 type II to proteoglycans. Differential effect of glycosaminoglycans on enzyme activity.
Sartipy P; Johansen B; Camejo G; Rosengren B; Bondjers G; Hurt-Camejo E
J Biol Chem; 1996 Oct; 271(42):26307-14. PubMed ID: 8824283
[TBL] [Abstract][Full Text] [Related]
14. Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis.
Schiering A; Menschikowski M; Mueller E; Jaross W
Atherosclerosis; 1999 May; 144(1):73-8. PubMed ID: 10381280
[TBL] [Abstract][Full Text] [Related]
15. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
[TBL] [Abstract][Full Text] [Related]
16. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
Wooton-Kee CR; Boyanovsky BB; Nasser MS; de Villiers WJ; Webb NR
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):762-7. PubMed ID: 14962950
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
[TBL] [Abstract][Full Text] [Related]
18. Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL.
Pruzanski W; Stefanski E; de Beer FC; de Beer MC; Vadas P; Ravandi A; Kuksis A
J Lipid Res; 1998 Nov; 39(11):2150-60. PubMed ID: 9799801
[TBL] [Abstract][Full Text] [Related]
19. Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet.
Rosengren B; Peilot H; Umaerus M; Jönsson-Rylander AC; Mattsson-Hultén L; Hallberg C; Cronet P; Rodriguez-Lee M; Hurt-Camejo E
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1579-85. PubMed ID: 16601231
[TBL] [Abstract][Full Text] [Related]
20. Cell adhesion molecules and secretory type II phospholipase A2 in relation to carotid atherosclerosis in patients with hypercholesterolaemia.
Wiklund O; Hulthe J; Bondjers G; Hurt-Camejo E
J Intern Med; 2001 May; 249(5):441-9. PubMed ID: 11350568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
